These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 35612970)

  • 1. First dose-ranging study of remimazolam in Japanese patients undergoing gastrointestinal endoscopy: Phase II investigator-initiated clinical trial.
    Ichijima R; Ikehara H; Maeda T; Sugita T; Horii T; Iwao A; Ogura K; Kusano C; Kondo Y; Suzuki T; Gotoda T
    Dig Endosc; 2022 Nov; 34(7):1403-1412. PubMed ID: 35612970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase Ib, dose-finding study of multiple doses of remimazolam (CNS 7056) in volunteers undergoing colonoscopy.
    Worthington MT; Antonik LJ; Goldwater DR; Lees JP; Wilhelm-Ogunbiyi K; Borkett KM; Mitchell MC
    Anesth Analg; 2013 Nov; 117(5):1093-100. PubMed ID: 24108261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of remimazolam in high risk colonoscopy: A randomized trial.
    Rex DK; Bhandari R; Lorch DG; Meyers M; Schippers F; Bernstein D
    Dig Liver Dis; 2021 Jan; 53(1):94-101. PubMed ID: 33243567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of remimazolam tosylate for sedation during upper gastrointestinal endoscopy: study protocol for a multicenter randomized controlled trial.
    Zhu H; Su Z; Huai X; Chen C; Zhang X; Zhou J; Su D
    Trials; 2022 Dec; 23(1):995. PubMed ID: 36510290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase IIb study comparing the safety and efficacy of remimazolam and midazolam in patients undergoing colonoscopy.
    Pambianco DJ; Borkett KM; Riff DS; Winkle PJ; Schwartz HI; Melson TI; Wilhelm-Ogunbiyi K
    Gastrointest Endosc; 2016 May; 83(5):984-92. PubMed ID: 26363333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Phase IIa, randomized, double-blind study of remimazolam (CNS 7056) versus midazolam for sedation in upper gastrointestinal endoscopy.
    Borkett KM; Riff DS; Schwartz HI; Winkle PJ; Pambianco DJ; Lees JP; Wilhelm-Ogunbiyi K
    Anesth Analg; 2015 Apr; 120(4):771-80. PubMed ID: 25502841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 50% and 95% effective doses of remimazolam tosilate with adjuvant sufentanil for sedation in patients with liver cirrhosis undergoing oesophagogastric varices screening endoscopy.
    Cao YH; Chi P; Zhou C; Lv WF; Quan ZF; Xue FS
    J Clin Pharm Ther; 2022 Dec; 47(12):2068-2073. PubMed ID: 36543252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part I. Safety, efficacy, and basic pharmacokinetics.
    Antonik LJ; Goldwater DR; Kilpatrick GJ; Tilbrook GS; Borkett KM
    Anesth Analg; 2012 Aug; 115(2):274-83. PubMed ID: 22190555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remimazolam tosilate compared with propofol for gastrointestinal endoscopy in elderly patients: a prospective, randomized and controlled study.
    Guo J; Qian Y; Zhang X; Han S; Shi Q; Xu J
    BMC Anesthesiol; 2022 Jun; 22(1):180. PubMed ID: 35689208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remimazolam: A Review in Procedural Sedation.
    Lee A; Shirley M
    Drugs; 2021 Jul; 81(10):1193-1201. PubMed ID: 34196946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychomotor Recovery Following Remimazolam-induced Sedation and the Effectiveness of Flumazenil as an Antidote.
    Chen X; Sang N; Song K; Zhong W; Wang H; Jiang J; Huang Y; Hu P
    Clin Ther; 2020 Apr; 42(4):614-624. PubMed ID: 32178858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remimazolam tosilate in upper gastrointestinal endoscopy: A multicenter, randomized, non-inferiority, phase III trial.
    Chen SH; Yuan TM; Zhang J; Bai H; Tian M; Pan CX; Bao HG; Jin XJ; Ji FH; Zhong TD; Wang Q; Lv JR; Wang S; Li YJ; Yu YH; Luo AL; Li XK; Min S; Li L; Zou XH; Huang YG
    J Gastroenterol Hepatol; 2021 Feb; 36(2):474-481. PubMed ID: 32677707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discharge readiness after remimazolam versus propofol for colonoscopy: A randomised, double-blind trial.
    Yao Y; Guan J; Liu L; Fu B; Chen L; Zheng X
    Eur J Anaesthesiol; 2022 Dec; 39(12):911-917. PubMed ID: 35796575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy.
    Rex DK; Bhandari R; Desta T; DeMicco MP; Schaeffer C; Etzkorn K; Barish CF; Pruitt R; Cash BD; Quirk D; Tiongco F; Sullivan S; Bernstein D
    Gastrointest Endosc; 2018 Sep; 88(3):427-437.e6. PubMed ID: 29723512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moderate sedation with single-dose remimazolam tosilate in elderly male patients undergoing transurethral resection of the prostate with spinal anesthesia: a prospective, single-arm, single-centre clinical trial.
    Zhao TY; Chen D; Sun H; Xu ZX; Lyu S; Wang T; Liu LL
    BMC Anesthesiol; 2022 Aug; 22(1):247. PubMed ID: 35927618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part II. Population pharmacokinetic and pharmacodynamic modeling and simulation.
    Wiltshire HR; Kilpatrick GJ; Tilbrook GS; Borkett KM
    Anesth Analg; 2012 Aug; 115(2):284-96. PubMed ID: 22253270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-down determination of the 90% effective dose (ED90) of remimazolam besylate for anesthesia induction.
    Lu Z; Zhou N; Li Y; Yang L; Hao W
    Ann Palliat Med; 2022 Feb; 11(2):568-573. PubMed ID: 35249335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of different doses of remimazolam tosylate for colonoscopy: single-center, prospective, randomized, double-blind, parallel trial.
    Zheng X; Ji J; Cheng H; Peng K; Liu L; Ji F
    Ann Transl Med; 2022 Nov; 10(22):1244. PubMed ID: 36544645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remimazolam: An Updated Review of a New Sedative and Anaesthetic.
    Hu Q; Liu X; Wen C; Li D; Lei X
    Drug Des Devel Ther; 2022; 16():3957-3974. PubMed ID: 36411859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remimazolam: First Approval.
    Keam SJ
    Drugs; 2020 Apr; 80(6):625-633. PubMed ID: 32274703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.